Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend (12mg)

$73.00

Size: 12mg
Contents: Fragment 176-191 (6mg), Mod GRF 1-29 (3mg), Ipamorelin (3mg)
Form: Lyophilized powder
Purity: >99%
SKU: P-FRAGMODIPAM-12

FREE Shipping on $200+ orders

Quantity 5 – 8 9 +
Discount 5% 10%
Price $69.35 $65.70

Description

Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend (12mg)

Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend (12mg) is a research-grade synthetic peptide blend manufactured exclusively for laboratory and scientific research applications. This formulation combines Fragment 176-191, Modified GRF (1-29), and Ipamorelin into a single 12mg lyophilized peptide blend, providing researchers with a convenient product for peptide chemistry, molecular biology, biotechnology, and other controlled laboratory investigations.

At Vial Peptides Labs, every peptide blend is manufactured using standardized laboratory procedures and undergoes comprehensive analytical testing to help verify product identity, purity, and batch consistency. Every vial is clearly labeled For Research Use Only – Not for Human Use and is intended solely for scientific research.


Product Specifications

  • Product Name: Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend
  • Total Strength: 12mg
  • Fragment 176-191: 2mg
  • Modified GRF (1-29): 5mg
  • Ipamorelin: 5mg
  • Grade: Research Grade
  • Appearance: White to off-white lyophilized powder
  • Purity: High Purity
  • Manufacturer: Vial Peptides Labs
  • Website: https://vialpeptideslabs.com/

Blend Components

Fragment 176-191

  • Synthetic peptide
  • 16 amino acid sequence
  • High-purity research grade

Modified GRF (1-29)

  • Also known as CJC-1295 NO DAC
  • Synthetic 29-amino-acid peptide
  • Research-grade laboratory material

Ipamorelin

  • Synthetic pentapeptide
  • High-purity research-grade peptide
  • Manufactured for laboratory research applications

Analytical Testing

Every production batch may undergo comprehensive laboratory evaluation, including:

  • Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC)
  • Mass Spectrometry (MS)
  • Molecular Identity Verification
  • Purity Assessment
  • Batch Documentation
  • Quality Control Review

These analytical procedures help support manufacturing consistency and product characterization.


Manufacturing Standards

Vial Peptides Labs follows standardized manufacturing procedures designed to produce premium research-grade peptide blends.

Our manufacturing process emphasizes:

  • Verified raw materials
  • Standardized peptide synthesis
  • Advanced purification techniques
  • Batch traceability
  • Comprehensive quality control
  • Transparent technical documentation

Storage Recommendations

For optimal product stability:

  • Store refrigerated between 2°C and 8°C.
  • Protect from direct sunlight, moisture, and excessive heat.
  • Keep the vial tightly sealed until laboratory use.
  • Follow proper laboratory handling procedures.

Packaging

Each vial is professionally packaged to help preserve product quality during storage and transportation.

Packaging includes:

  • Secure laboratory vial
  • Premium Vial Peptides Labs product label
  • Batch identification
  • Protective shipping materials

Research Use Only

Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend (12mg) is supplied strictly for laboratory research purposes only.

Not for human consumption, therapeutic use, clinical application, diagnostic use, or veterinary use.


Why Choose Vial Peptides Labs?

Researchers choose Vial Peptides Labs because of our commitment to quality, consistency, and scientific excellence.

We provide:


Related Products

  • Fragment 176-191 (5mg)
  • CJC-1295 NO DAC (Mod GRF 1-29) (5mg)
  • CJC-1295 DAC (5mg)
  • CJC-1295 & Ipamorelin Blend (10mg)
  • CJC-1295 & GHRP-2 Blend (10mg)
  • CJC-1295 & GHRP-6 Blend (10mg)
  • Ipamorelin (5mg)
  • AOD-9604 (5mg)

Reviews

There are no reviews yet.

Be the first to review “Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend (12mg)”

Your email address will not be published. Required fields are marked *